Nathalie works collaboratively with the Innovation Factory, Cancer Research Horizons and the Manchester Cancer Research Centre (including the Christie NHS Trust and MFT. Her title is Cancer Commercialisation and Innovation Lead.

This role was created to identify innovations, intellectual property (IP) and opportunities for commercialisation, collaboration and subsequently providing the best road maps for translation into patient impact in cancer.

Nathalie is the point-of-contact for all the cancer research groups and clinicians working within the partner organisations and will support scientists and clinicians in identifying new high-value IP and innovations resulting from their research.

She is an accomplished science professional with over 16 years’ experience in the cancer science field, most recently leading and managing multiple research programmes into personalised medicine and translational science approaches for melanoma, melanoma biomarkers, the role of UVR in melanomagenesis, and collaborative projects with the Drug Discovery Unit across multiple targets.

Prior to this, Nathalie worked at the Ludwig Institute for Cancer Research in Melbourne, Australia as a Postdoctoral Research Training Fellow in the Tumour Targeting Group and prior to that at the Institute for Cancer Research, London also as a Postdoctoral Research Training Fellow in the Signal Transduction Group.

She has a PhD in Developmental Biology from the Institute of Child Health at UCL and is currently studying for an MBA at the University of Manchester.

Nathalie's involvement